Abstract:Bioactive phospholipids (PL) from different origins varied greatly in the chemical constitutions, especially the fatty acid compositions, which might influence its physiological activities in turn. In the study, egg yolk phospholipids (EGG‐PL), soybean phospholipids (SOY‐PL), and marine docosahexaenoic acid‐enriched phospholipids (DHA‐PL) were administered to high fat (HF) diet‐induced obese C57BL/6J mice for 7 weeks to compare their effects on obesity‐related metabolic disorders. EGG‐PL, SOY‐PL, and DHA‐PL significantly decreased epididymal adipose tissue weights, reduced blood pressures and lowered hepatic TG levels. Only DHA‐PL efficiently decreased perirenal adipose tissue weights, and reduced serum glucose, insulin, IL‐6 and TG levels. These three phospholipids significantly decreased delta‐9 desaturation indices, the ratio of oleic acid versus stearic acid, and reduced the enzyme activities and gene expressions of FAS in the liver, while DHA‐PL also markedly reduced mRNA levels of SREBP‐1c and SCD‐1. Hepatic total catalase and peroxisomal β‐oxidation activities were significantly increased after DHA‐PL supplementation. These data indicated that the biological effects of PL with different fatty acid compositions were not completely equivalent and DHA‐PL, rich in n‐3 PUFA, was more efficient in ameliorating obesity‐related metabolic disorders, especially the lipid metabolism, attributing to the better inhibition of SREBP‐1c mediated lipogenesis and the elevation of hepatic lipolysis. Practical applications: This research gives the public the guidance of the dietary intake of bioactive phospholipids from the perspective of nutrition and it supplies informational support for the development of functional foods containing DHA‐PL participating to the prevention of chronic metabolic diseases in humans. In another aspect, this research also provides an important direction for the development and utilization of marine aquatic raw materials since these materials are the best sources of n‐3 polyunsaturated fatty acid enriched‐phospholipids. Dietary egg yolk phospholipids, soybean phospholipids, and marine docosahexaenoic acid‐enriched phospholipids (DHA‐PL) could efficiently improve obesity‐related metabolic disorders in mice. Notably, DHA‐PL, rich in n‐3 PUFA, exhibited the best ameliorative effects, especially on the lipid metabolism, which could be attributed to the better inhibition of SREBP‐1c mediated lipogenesis and the elevation of hepatic lipolysis. Such findings would be useful in the development of functional foods containing DHA‐PL participating to prevent chronic metabolic disease in humans.

Lipidome remodeling activities of DPA-EA in palmitic acid-stimulated HepG2 cells and the in vivo anti-obesity effect of the DPA-EA and DHA-EA mixture prepared from algae oil

N-3 Polyunsaturated Fatty Acids in Phospholipid or Triacylglycerol Form Attenuate Nonalcoholic Fatty Liver Disease Via Mediating Cannabinoid Receptor 1/adiponectin/ceramide Pathway.

Comparative Study of DHA‐enriched Phospholipids and EPA‐enriched Phospholipids on Metabolic Disorders in Diet‐induced‐obese C57BL/6J Mice

Dietary Phospholipids Alleviate Diet-Induced Obesity in Mice: Which Fatty Acids and Which Polar Head

Docosahexaenoic Acid‐enriched Phospholipids Exhibit Superior Effects on Obesity‐related Metabolic Disorders to Egg Yolk Phospholipids and Soybean Phospholipids in Mice

Comparative Analysis of EPA/DHA-PL Forage and Liposomes in Orotic Acid-Induced Nonalcoholic Fatty Liver Rats and Their Related Mechanisms

Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells

The exogenous natural phospholipids, EPA-PC and EPA-PE, contributes to ameliorate lipid accumulation and inflammation via activation of PPARα/γ

Hydroxyeicosapentaenoic Acids and Epoxyeicosatetraenoic Acids Attenuate Early Occurrence of Nonalcoholic Fatty Liver Disease

Effects of Fatty Acid-Ethanol Amine (FA-EA) Derivatives on Lipid Accumulation and Inflammation.

Dietary Eicosapentaenoic Acid Containing Phosphoethanolamine Plasmalogens Remodels the Lipidome of White Adipose Tissue and Suppresses High-Fat Diet Induced Obesity in Mice.

The exogenous natural phospholipids, EPA-PC and EPA-PE, contribute to ameliorate inflammation and promote macrophage polarization.

Effects of DHA-enriched Phospholipids on Lipid Metabolism in Diet-Induced Obese C57 BL/6 J Mice Model

Discovery of New DHA Ethanolamine Derivatives As Potential Anti-Inflammatory Agents Targeting Nur77.

Eicosapentaenoic Acid-Containing Phosphatidylcholine Alleviated Lipid Accumulation in Orotic Acid-Induced Non-Alcoholic Fatty Liver

Punicic acid ameliorates obesity-related hyperlipidemia and fatty liver in mice via regulation of intestinal flora and lipopolysaccharide-related signaling pathways

Phycobiliprotein Peptide Extracts from Arthrospira platensis Ameliorate Nonalcoholic Fatty Liver Disease by Modulating Hepatic Lipid Profile and Strengthening Fat Mobilization

Dehydroepiandrosterone alleviates oleic acid-induced lipid metabolism disorders through activation of AMPK-mTOR signal pathway in primary chicken hepatocytes

The Mechanistic Study of Diacylglycerol in Ameliorating Non-Alcoholic Fatty Liver and Systemic Lipid Accumulation

Phycobiliprotein Peptide Extracts from <i>Arthrospira platensis</i> Ameliorate Nonalcoholic Fatty Liver Disease by Modulating Hepatic Lipid Profile and Strengthening Fat Mobilization

Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice